APPLY NOW Apply NowUCSI Radio UCSI Radio

Assistant Professor Dr Marwan Abdelmahmoud Abdelkarim Maki

Head of Programme, Bachelor of Formulation Science (HONS) | Department of Pharmaceutical Technology

Academic Qualifications

PhD in Pharmaceutical Sciences
Master of Sciences in Pharmaceutical Technology
Bachelor of Clinical Pharmacy

Areas of Interest
Drug delivery systems using natural and synthetic polymers.
Nanotechnology and its role in enhancing drug bioavailability and targeting.
Biomolecules for tissue regeneration and healing.
Peptide chemistry and its therapeutic applications.
Professional Bodies Membership:

Sudan Medical Council life member

Research

Current research project (PI/Co-PI)

Grants

Collaboration

Status

Fabrication and evaluation of ferulic acid-enriched chitosan-based in situ hydrogels reinforced with chondroitin sulphate for cellular regeneration.

 

Research Excellence and Innovation Grant (REIG) by UCSI

University

 

Üsküdar University, Turkey

On-going

Development and evaluation of oral gel (sachet) containing poly herbal TC-16-loaded nanostructured nanocarrier for uterine fibroids.

 

Research Excellence and Innovation Grant (REIG) by UCSI

University

 

Saveetha University, India

On-going

Carbon quantum dots (CQDs) from curuma aromatica: Green synthesis and in vitro characterisation

Research Excellence and Innovation Grant (REIG) by UCSI University

 
Presidency University, IndiaOn-going

 

Supervision:

PhD students (current)

  • Ayesha Siddiqua

  • Farah Abdulhessein Shakir

  • Fatimah Ahmed Challoob

PhD students (completed)

-

Master students (current)

  • Cao Menghan

  • Wu Yan

Master students (completed)

  • Marwan Salem Bahaj

Undergraduate students (current)

  • Tan Zhen Yeow

Undergraduate students (completed)

  • Felix Tye Kai Ler

  • Chua Jie Xi

  • Audrey Phan Sing Yu

Publications

  1. Tan, K.F., Chia, L.Y., Maki, M.A., Cheah, S.C., In, L.L., Kumar, P.V (2025). Gold nanocomposites in colorectal cancer therapy: Characterisation, selective cytotoxicity and migration inhibition. Naunyn-Schmiedeberg's Archives of Pharmacology. Jan 29:1-29.

  2. Al-Sahlawi, F., Alabdali, A.Y., Chinnappan, S., Al-Samydai, A., Maki, M.A. (2024). Polymer-based nanoparticles in targeted cancer therapy: A review. Journal of Applied Pharmaceutical Science. Sep 5;14(9):057-68.

  3. Bahaj, M.S., Maki, M.A., Rao, K.S., Kumar, P.V. (2024). Progressive exploration on the influence of natural polymers and emerging biomaterials in advanced wound care strategies. Indian Journal of Biochemistry and Biophysics (IJBB).  Feb 20;61(3):127-44.

  4. Maki, M.A., Teng, M.S., Tan, K.F., Kumar, P.V. (2023) Polyamidoamine-stabilised and hyaluronic acid-functionalised gold nanoparticles for cancer therapy. OpenNano. Sep 1;13:100182.

  5. Chia, L.Y., Kumar, P.V., Maki, M.A., Ravichandran, G., Thilagar, S. (2022). A review: The antiviral activity of cyclic peptides. International Journal of Peptide Research and Therapeutics. Dec 1;29(1):7.

  6. Tee, Y.N., Kumar, P.V., Maki, M.A., Elumalai, M., Rahman, S.A., Cheah, S.C. (2021). Mucoadhesive low molecular chitosan complexes to protect rHuKGF from proteolysis: In-vitro characterisation and FHs 74 int cell proliferation studies. Current Pharmaceutical Biotechnology. Jun 1;22(7):969-82.

  7. Maki, M.A., Kumar, P.V., Elumalai, M., Bayazeid, O. (2021). In silico-based approach to investigate the ability of PEGylated rapamycin to inhibit galectin-3. Current Drug Discovery Technologies. May 1;18(3):451-6.

  8. Maki, M.A., Cheah, S.C., Bayazeid, O., Kumar, P.V. (2020). Cyclodextrin inclusion complex inhibits circulating galectin-3 and FGF-7 and affects the reproductive integrity and mobility of Caco-2 cells. Scientific Reports. Oct 15;10(1):17468.

  9. Maki, M.A., Elumalai, M., Ahamed, H.N., Kumar, P.V. (2020). Design a lymphatic specific delivery system of rHuKGF in rats and assessment of intestinal lymphatic uptake. Biomed. Eng. Int. 2:0066-74.

  10. Kumar, P.V., Maki, M.A., Yeong, S. W., Lee, M. T., Elumalai, M., Cheah, S.C., Raghavan, B., Majeed, A.B. (2019). Rabbit as an animal model for pharmacokinetics studies of enteric capsule contains recombinant human keratinocyte growth factor loaded chitosan nanoparticles. Current Clinical Pharmacology. Aug 1;14(2):132-40.

Editorial Board Member

Theoretical and Natural Science

Awards and Recognitions

  • Merit Award, Malaysian Technology Expo, 2023.

  • Silver Medal, 31st International Invention, Innovation and Technology Exhibition Malaysia, 2020.

  • Best oral presentation at the International Research Conference on Pharmaceutical and Allied Sciences (IRCPAS), Malaysia, 2020.

  • UCSI University Trust Graduate Assistantship, 2017.

 

Other achievements

External examiner (dissertation) 

  • Master of Science. Development of multi-epitopes vaccine against 1 Human Papilloma Virus-16using the l1 and l22 proteinsas immunogens. National University, Sudan.

  • Master of Science. An in-silico technique: Prediction of unknown protein structure from sequences by homology. National University, Sudan.

  • Master of Science. In-silico analysis of multidrug efflux pump RND family MexA MexB proteins encoded by the pseudomonas aeruginosa NUBRI-P strain genome. National University, Sudan. 

  • Master of Science. An in-silico technique: Prediction of unknown protein structure from sequences by homology. National University, Sudan.

  • Master of Science. A novel multi-epitope vaccine candidates against Jaagsiekte sheep retrovirus from the envelope and gag proteins: An in-silico approach. NationaL University, Sudan.